Sarah Hughes

A private equity-backed firm is offering a 'Fortune 500' toolkit to save local auto shops. But does this empowerment come at the cost of independence?

Building materials giant CRH is spending billions on its own stock. We investigate if this rewards shareholders or signals a retreat from future investment.

The used car retailer touts record profits and slashed debt, but a look beneath the surface reveals a story of centralized control and growing influence.

Changan's flashy Brazil debut with Gisele Bündchen masks a high-stakes play in a market wary of the broken promises of foreign automakers.

A HK$10 billion program is funding a medical revolution. But can AI-driven breakthroughs in health tech overcome the profound challenges of ethics and equity?

Changan's lavish Brazil debut with Gisele Bündchen masks a complex deal with powerhouse CAOA, reshaping Latin America's auto market and its ties to China.

A new AI tool promises to de-risk corporate mergers by measuring human capital. But does quantifying team resilience come at the cost of employee privacy?

GenScript's industry forum signals a pivotal moment for cell and gene therapy. But can the sector overcome manufacturing hurdles, investment risks, and the need for realistic expectations to deliver on its promise?

A new philanthropic model is emerging, prioritizing quantifiable results over traditional giving. The GitLab Foundation aims for a 100x return on investment, raising questions about accountability and the future of social impact.

New research reveals a disconnect between men acknowledging fertility as a shared issue and actually seeking care. Stigma, cost, and fear are key barriers, prompting calls for more inclusive benefits.

GenPrime’s expansion into Singapore and Manila reflects a growing, tech-driven fertility market, but also highlights the urgent need to address declining birth rates and improve access to care in the region.

Overture Life's CE Mark approval for its DaVitri platform signals a shift in assisted reproductive technology. But can automation truly lower costs and improve access to fertility treatment?

Hong Kong-based entrepreneur Dr. James Liang is investing $64 million into a new foundation aiming to reverse declining birth rates through economic support, cultural shifts, and policy research. Can philanthropy solve a demographic time bomb?

New study reveals strong public support for international collaboration, as the Rockefeller Foundation launches a $50M initiative to ‘Build the Shared Future.’ Can this public mandate translate into real policy change?

A unique partnership between the Green Bay Packers, Tork, and Rawhide Youth Services is scoring vital hygiene products for at-risk youth. How a performance-based donation model is making a tangible difference.

Following Hurricane Melissa, the International Poverty Forum is sending a major aid shipment to Jamaica—but with a key difference: everything is new. This approach, prioritizing dignity and efficiency, is reshaping disaster relief.

A Silicon Valley packaging company is investing $500,000 in reforestation efforts following devastating wildfires. But is corporate-funded restoration a sustainable solution or simply greenwashing?

A new report reveals a pathway to expand school meal programs to 8 million more children without increasing costs, while bolstering food security and building resilience to climate change through regenerative agriculture.

Fortitude Re’s donation to the Cumberland River Compact signals a growing trend: reinsurance companies are increasingly investing in environmental sustainability alongside financial returns. This investment aims to bolster Tennessee’s ecosystems and educate the next generation of environmental stewards.

A new clinical trial at MD Anderson Cancer Center, funded by The DeGregorio Family Foundation, is combining surgery, chemotherapy, and engineered NK cell therapy to target a particularly deadly form of gastric cancer.